NDPSC record of reasons, 50th meeting, 26-28 June 2007
National Drugs and Poisons Schedule Committee
The Record of the Reasons contains the basis of scheduling decisions and other outcomes arising from the meeting. Please note that the Record of the Reasons includes extracts from the NDPSC minutes which have been edited to remove confidential information.
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
NDPSC Record of reasons, Meeting 50 (pdf,583kb)
Contents
Glossary
1. Preliminary matters
- 1.7 Procedural matters
- 1.7.1 Operations/Policies of the Committee
- 1.7.1.1 Draft template for scheduling/rescheduling
- 1.7.1.2 Item deleted
- 1.7.1.3 Policy for referencing enantiomers
- 1.7.1.4 Item deleted
- 1.7.1.5 Item deleted
- 1.7.1 Operations/Policies of the Committee
- 1.8 NDPSC working parties
- 1.8.1 Trans-Tasman Harmonisation Working Party
- 1.8.1.1 Cadmium compounds and cadmium sulphide
- 1.8.1.2 Stimulant laxatives
- 1.8.1 Trans-Tasman Harmonisation Working Party
2. Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons
- 2.1 SUSDP, Part 1
- 2.1.1 Interpretation of aerosol concentration
- 2.1.2 Reverse schedule label flexibility
Agricultural/veterinary, industrial and domestic chemicals
3. Matters arising from the Minutes of the previous meeting
4. Other outstanding matters from previous meetings
- 4.1 Liquid hydrocarbons
- 4.2 Clothianidin
- 4.3 4-Aminopyridine and metallic phosphides
- 4.4 Pyrasulfotole
- 4.5 2,4-Dichlorophenoxyacetic acid (2,4-D)
6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority
- 6.1 Diquat
- 6.2 Trilostane
- 6.3 Pyriprole
7. Matters referred by Office of Chemical Safety (OCS) Branch
- 7.1 Formaldehyde and paraformaldehyde
8. Other matters for consideration
9. Information items (Ag/vet, industrial & domestic chemicals)
Pharmaceuticals
10. Matters arising from the Minutes of the previous meeting
- 10.1 Orlistat
- 10.2 Vitamin A
- 10.2.2 Selenium
- 10.3 Ranitidine
- 10.4 Aspirin when combined with paracetamol, caffeine or salicylamide
11. Other outstanding matters from previous meetings
- 11.1 Sedating antihistamines - brompheniramine, chlorpheniramine, dexchlorpheniramine, diphenhydramine, doxylamine, pheniramine,promethazine, trimeprazine and triprolidine
- 11.2 Potassium chloride
- 11.3 Fluoride
- 11.4 Pantoprazole
- 11.5 Paracetamol and caffeine
12. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 12.1 SUSDP, Part 4
- 12.1.1 Paracetamol and phenylephrine
- 12.1.2 Lanthanum
- 12.2 SUSDP, Part 5
13. Matters referred by registration process for Prescription Medicines
- 13.1 New substances (not seen before by NDPSC)
- 13.1.1 Dasatinib
- 13.1.2 Rimonabant
- 13.1.3 Sitaxentan
- 13.1.4 Perflutren
- 13.1.5 Paricalcitol
- 13.1.6 Factor VIII inhibitor bypassing fraction
- 13.1.7 Ranibizumab
- 13.1.8 Pentastarch
- 13.1.9 Galsulfase
15. Matters referred by the Medicines Evaluation Committee (MEC)
16. Matters referred by the Medicines Classification Committee (MCC) of New Zealand
- 16.1 MCC new medicines
- 16.2 Propamidine and dibromopropamidine
- 16.3 Boron/boric acid
- 16.4 Choline salicylate
- 16.5 Naproxen and mefenamic acid
- 16.6 Mercuric oxide/mercury
17. Minutes of the Adverse Drug Reactions Advisory Committee (ADRAC)
18. Minutes of the Medical Device Evaluation Committee (MDEC)
19. Items deleted
20. Gazettal notices
21. Amendments to the SUSDP
- 21.1 Items deleted
- 21.2 Editorials and errata - appropriate authority definition, drotrecogin, hydrocortisone, nicotine, indoxacarb, maldison/malathion, methylandrostanolone, nicotine acid
- 21.3 SUSDP amendment